Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study
Bachy, Emmanuel, Seymour, John F, Feugier, Pierre, Offner, Fritz, López-Guillermo, Armando, Belada, David, Xerri, Luc, Catalano, John V, Brice, Pauline, Lemonnier, François, Martin, Alejandro, Casasnovas, Olivier, Pedersen, Lars M, Dorvaux, Véronique, Simpson, David, Leppa, Sirpa, Gabarre, Jean, da Silva, Maria G, Glaisner, Sylvie, Ysebaert, Loic, Vekhoff, Anne, Intragumtornchai, Tanin, Le Gouill, Steven, Lister, Andrew, Estell, Jane A, Milone, Gustavo, Sonet, Anne, Farhi, Jonathan, Zeuner, Harald, Tilly, Hervé, Salles, Gilles
Published in Journal of clinical oncology (01.11.2019)
Published in Journal of clinical oncology (01.11.2019)
Get full text
Journal Article
Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy
Klanova, Magdalena, Oestergaard, Mikkel Z, Trněný, Marek, Hiddemann, Wolfgang, Marcus, Robert, Sehn, Laurie H, Vitolo, Umberto, Bazeos, Alexandra, Goede, Valentin, Zeuner, Harald, Knapp, Andrea, Sahin, Deniz, Spielewoy, Nathalie, Bolen, Christopher R, Cardona, Andres, Klein, Christian, Venstrom, Jeffrey M, Nielsen, Tina, Fingerle-Rowson, Günter
Published in Clinical cancer research (01.08.2019)
Published in Clinical cancer research (01.08.2019)
Get full text
Journal Article
Updated efficacy and safety of entrectinib in patients (pts) with locally advanced/metastatic NTRK fusion-positive (fp) non-small cell lung cancer (NSCLC)
Cho, Byoung Chul, Chiu, Chao-Hua, Massarelli, Erminia, Buchschacher, Gary L, Goto, Koichi, Overbeck, Tobias R., Loong, Herbert H. F., Chee, Cheng E., Garrido, Pilar, Heinzmann, Sebastian, Bordogna, Walter, Zeuner, Harald, Osborne, Stuart, John, Tom
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Updated analysis of the efficacy and safety of entrectinib in patients (pts) with locally advanced/metastatic NTRK fusion-positive ( NTRK -fp) solid tumors
Krzakowski, Maciej Jerzy, Lu, Shun, Cousin, Sophie, Smit, Egbert F., Springfeld, Christoph, Goto, Koichi, Garrido, Pilar, Chung, Christine H., Lin, Jessica Jiyeong, Bray, Victoria J., Pitcher, Bethany, Zeuner, Harald, Patel, Siddhartha, Bordogna, Walter, Gelderblom, Hans
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer
Cho, Byoung Chul, Chiu, Chao-Hua, Massarelli, Erminia, Buchschacher, Gary L, Goto, Koichi, Overbeck, Tobias R, Loong, Herbert H F, Chee, Cheng E, Garrido, Pilar, Dong, Xiaorong, Fan, Yun, Lu, Shun, Schwemmers, Sven, Bordogna, Walter, Zeuner, Harald, Osborne, Stuart, John, Thomas
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2024)
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2024)
Get full text
Journal Article
Brief Report: Updated Efficacy and Safety Data From an Integrated Analysis of Entrectinib in Locally Advanced/Metastatic ROS1 Fusion-Positive Non–Small-Cell Lung Cancer
Fan, Yun, Drilon, Alexander, Chiu, Chao-Hua, Loong, Herbert H.F., Siena, Salvatore, Krzakowski, Maciej, Dziadziuszko, Rafal, Zeuner, Harald, Xue, Cloris, Krebs, Matthew G.
Published in Clinical lung cancer (01.03.2024)
Published in Clinical lung cancer (01.03.2024)
Get full text
Journal Article
Abstract C149: Efficacy and safety of entrectinib in patients (pts) with locally advanced/metastatic NTRK or ROS1 fusion-positive (fp) solid tumors, not evaluable for the primary endpoint of STARTRK-2
Liu, Stephen V, Peeters, Marc, Ahn, Myung-Ju, Lin, Jessica J, Ohe, Yuichiro, Yau, Chung Cheung Thomas, Bordogna, Walter, Osborne, Stuart, Schwemmers, Sven, Zeuner, Harald, Goto, Koichi
Published in Molecular cancer therapeutics (01.12.2023)
Published in Molecular cancer therapeutics (01.12.2023)
Get full text
Journal Article
Baseline PET-Derived Metabolic Tumor Volume Metrics Did Not Predict Outcomes in Follicular Lymphoma Patients Treated with First-Line Immunochemotherapy and Antibody Maintenance in the Phase III GALLIUM Study
Barrington, Sally F, Trotman, Judith, Sahin, Deniz, Belada, David, Davies, Andrew, MacEwan, Robert, Owen, Carolyn, Ptáčník, Václav, Rosta, András, Hiddemann, Wolfgang, Marcus, Robert, Nielsen, Tina, Mattiello, Federico, Zeuner, Harald, Meignan, Michel
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Low Peripheral Blood NK Cell Count Is Associated with Worse Clinical Outcome in Patients with Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results from the Frontline Phase 3 GALLIUM and GOYA Trials
Klanova, Magdalena, Oestergaard, Mikkel Z., Trněný, Marek, Hiddemann, Wolfgang, Marcus, Robert, Sehn, Laurie H., Vitolo, Umberto, Bazeos, Alexandra, Goede, Valentin, Zeuner, Harald, Knapp, Andrea, Sahin, Denis, Danesi, Nathalie, Bolen, Christopher, Robson, Susan, Venstrom, Jeffrey M., Nielsen, Tina, Fingerle-Rowson, Günter
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Obinutuzumab-Based Immunochemotherapy Prolongs Progression-Free Survival and Time to Next Anti-Lymphoma Treatment in Patients with Previously Untreated Follicular Lymphoma: Four-Year Results from the Phase III GALLIUM Study
Townsend, William, Buske, Christian, Cartron, Guillaume, Cunningham, David, Dyer, Martin JS, Gribben, John G., Hess, Georg, Ishikawa, Takayuki, Keller, Ulrich, Kneba, Michael, Malladi, Ram, Neidhart, Jeffrey D, Rusconi, Chiara, Zhu, Jun, Catalani, Olivier, Knapp, Andrea, Zeuner, Harald, Herold, Michael, Hiddemann, Wolfgang, Marcus, Robert
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Long Term Follow-up of the PRIMA Study: Half of Patients Receiving Rituximab Maintenance Remain Progression Free at 10 Years
Salles, Gilles Andre, Seymour, John Francis, Feugier, Pierre, Offner, Fritz, Lopez-Guillermo, Armando, Belada, David, Xerri, Luc, Bouabdallah, Reda, Catalano, John, Brice, Pauline, Haioun, Corinne, Martín, Alejandro, Pedersen, Lars Moller, Delmer, Alain Jacques, Simpson, David, Leppa, Sirpa, Soubeyran, Pierre, Casasnovas, Rene-Olivier, Intragumtornchai, Tanin, Ribrag, Vincent, Silva, Maria Gomes, Nicolas-Virelizier, Emmanuelle, Lister, Thomas, Estell, Jane, Milone, Gustavo, Sonet, Anne, Assemat, Julie, Zeuner, Harald, Coiffier, Bertrand, Tilly, Herve
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Brief Report: Updated Efficacy and Safety Data From an Integrated Analysis of Entrectinib in Locally Advanced/Metastatic ROS1 Fusion-Positive Non-Small-Cell Lung Cancer
Fan, Yun, Drilon, Alexander, Chiu, Chao-Hua, Loong, Herbert H F, Siena, Salvatore, Krzakowski, Maciej, Dziadziuszko, Rafal, Zeuner, Harald, Xue, Cloris, Krebs, Matthew G
Published in Clinical lung cancer (01.03.2024)
Published in Clinical lung cancer (01.03.2024)
Get full text
Report